Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract Start Printed Page 19183proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, NDS-R Fluoride Component.
Date: May 4, 2001.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Room 7214, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892-7924 (Telephone Conference Call).
Contact Person: C. James Scheirer, Chief, Review Branch, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, Rockledge Center II, 6701 Rockledge Drive, Suite 7216, Bethesda, MD 20892-7924, 301-435-0266.Start Signature
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Disease and Disorders Research, National Institutes of Health, HHS)
Dated: April 6, 2001.
Laverne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-9255 Filed 4-12-01; 8:45 am]
BILLING CODE 4140-01-M